Serum microRNA-205 as a novel biomarker for cervical cancer patients

Cancer Cell International

Volumn 14, Issue 1, 2014, Pages

  Ma, Quanhui ^a   Wan, Guiping ^a   Wang, Shuxia ^a   Yang, Wanwei ^a   Zhang, Jiaming ^a   Yao, Xiaoming ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Cervical cancer; Diagnosis; Prognosis; Serum miR 205

Indexed keywords

MICRORNA 205;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

EID: 84906827630     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/s12935-014-0081-0     Document Type: Article

References (22)

1. Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, Kluhsman BC, Osann K, Newlands E, Seckl MJ, Hancock B, Cella D. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr 2005, 34:94-98. 10.1093/jncimonographs/lgi017, 15784834.
2. Paradkar PH, Joshi JV, Mertia PN, Agashe SV, Vaidya RA. Role of cytokines in genesis, progression and prognosis of cervical cancer. Asian Pac J Cancer Prev 2014, 15:3851-3864. 24935564.
3. Mariuzzi G, Santinelli A, Valli M, Sisti S, Montironi R, Mariuzzi L, Alberti R, Pisani E. Cytometric evidence that cervical intraepithelial neoplasia I and II are dysplasias rather than true neoplasias. An image analysis study of factors involved in the progression of cervicallesions. Anal Quant Cytol Histol 1992, 14:137-147. 1590897.
4. Behtash N, Mehrdad N. Cervical cancer: screening and prevention. Asian Pac J Cancer Prev 2006, 7:683-686. 17250453.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
6. Williams AE. Functional aspects of animal microRNAs. Cell Mol Life Sci 2008, 65:545-562. 10.1007/s00018-007-7355-9, 17965831.
7. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009, 285:116-126. 10.1016/j.canlet.2009.04.031, 19464788.
8. Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 2012, 41:1897-1912. 23026890.
9. Anindo MI, Yaqinuddin A. Insights into the potential use of microRNAs as biomarker in cancer. Int J Surg 2012, 10:443-449. 10.1016/j.ijsu.2012.08.006, 22906693.
10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518. 10.1073/pnas.0804549105, 18663219.
11. Wittmann J, Ja¨ck HM. Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 1806, 2010:200-207.
12. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008, 3:e2557. 10.1371/journal.pone.0002557, 18596939.
13. Xie H, Zhao Y, Caramuta S, Larsson C, Lui WO. miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One 2012, 7:e46990. 10.1371/journal.pone.0046990, 23056551.
14. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009, 27:2030-2037. 10.1200/JCO.2008.19.4134, 19273703.
15. Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang SZ, Ren XB, Cao S. MiR-205 in cancer: an angel or a devil?. Eur J Cell Biol 2013, 92:54-60. 10.1016/j.ejcb.2012.11.002, 23279926.
16. Moldovan L, Batte K, Wang Y, Wisler J, Piper M: Analyzing the circulating microRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR.Methods Mol Biol 2013, 1024:129-145.
17. Orang AV, Safaralizadeh R, Hosseinpour Feizi MA, Somi MH. Diagnostic and prognostic value of miR-205 in colorectal cancer. Asian Pac J Cancer Prev 2014, 15:4033-4037. 10.7314/APJCP.2014.15.2.577, 24935592.
18. Zheng H, Zhang L, Zhao Y, Yang D, Song F, Wen Y, Hao Q, Hu Z, Zhang W, Chen K. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS One 2013, 8:e77853. 10.1371/journal.pone.0077853, 24223734.
19. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009, 27:2030-2037. 10.1200/JCO.2008.19.4134, 19273703.
20. Lukaszuk K, Liss J, Wozniak I, Sliwinski W, Emerich J, Wojcikowski C. HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study. J Clin Pathol 2004, 57:472-476. 10.1136/jcp.2003.009852, 15113853.
21. Zhao S, Yao D, Chen J, Ding N. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Genet Test Mol Biomarkers 2013, 17:631-636. 10.1089/gtmb.2013.0085, 23819812.
22. Chen J, Yao D, Li Y, Chen H, He C, Ding N, Lu Y, Ou T, Zhao S, Li L, Long F. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med 2013, 32:557-567. 23799609.